Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study.
暂无分享,去创建一个
Mahboob Rahman | B. Kestenbaum | S. Waikar | H. Feldman | A. Hoofnagle | M. Shlipak | S. Seliger | J. Lash | T. Shafi | Chi-yuan Hsu | L. Zelnick | Yan Chen | Rupal Mehta | Ke Wang | C. Hsu | Jessica O. Becker
[1] N. Shinomiya,et al. Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression , 2018, Scientific Reports.
[2] C. Investigators. Self-reported Medication Adherence and CKD Progression , 2018 .
[3] J. Perl,et al. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[4] Anna C. Porter,et al. Self-reported Medication Adherence and CKD Progression , 2018, Kidney international reports.
[5] Wei Wu,et al. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut–liver–kidney axis , 2017, The Journal of Biological Chemistry.
[6] Mahboob Rahman,et al. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[7] G. Beck,et al. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. , 2017, Kidney international.
[8] B. Kestenbaum,et al. Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion. , 2017, Clinical chemistry.
[9] T. Meyer,et al. Tubular Secretion in CKD. , 2016, Journal of the American Society of Nephrology : JASN.
[10] R. Blantz,et al. Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[11] J. Wetzels,et al. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[12] Don C Rockey,et al. Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.
[13] T. Niwa,et al. Indoxyl sulfate upregulates prorenin expression via nuclear factor-κB p65, signal transducer and activator of transcription 3, and reactive oxygen species in proximal tubular cells. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[14] Yi‐Jen Chen,et al. The Uremic Toxin Indoxyl Sulfate Increases Pulmonary Vein and Atrial Arrhythmogenesis , 2015, Journal of cardiovascular electrophysiology.
[15] Sanjay K. Nigam,et al. What do drug transporters really do? , 2014, Nature Reviews Drug Discovery.
[16] T. Abe,et al. The kidney and uremic toxin removal: glomerulus or tubule? , 2014, Seminars in nephrology.
[17] Mahboob Rahman,et al. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] L. P. Van den Heuvel,et al. Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP). , 2013, Biochimica et biophysica acta.
[19] R. Vasan,et al. A combined epidemiologic and metabolomic approach improves CKD prediction. , 2013, Journal of the American Society of Nephrology : JASN.
[20] T. Meyer,et al. Numerous protein-bound solutes are cleared by the kidney with high efficiency , 2013, Kidney international.
[21] M. Joffe,et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] Harold I Feldman,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.
[23] Raymond Vanholder,et al. Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.
[24] H. Feldman,et al. Measured GFR does not outperform estimated GFR in predicting CKD-related complications. , 2011, Journal of the American Society of Nephrology : JASN.
[25] F. Leblond,et al. Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats , 2011, Drug Metabolism and Disposition.
[26] A. Go,et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[27] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[28] R. Unwin,et al. The Not So ‘Mighty Chondrion’: Emergence of Renal Diseases due to Mitochondrial Dysfunction , 2006, Nephron Physiology.
[29] S. Fukuhara,et al. Health-Related Quality of Life of Predialysis Patients with Chronic Renal Failure , 2006, Nephron Clinical Practice.
[30] Y. Takekuma,et al. Structure-affinity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolites. , 2005, Biochimica et biophysica acta.
[31] H. Endou,et al. Altered renal elimination of organic anions in rats with chronic renal failure. , 2005, Biochimica et biophysica acta.
[32] T. Akizawa,et al. Protective Effect of an Oral Adsorbent on Renal Function in Chronic Renal Failure: Determinants of its Efficacy in Diabetic Nephropathy , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[33] H. Koepsell,et al. The SLC22 drug transporter family , 2004, Pflügers Archiv.
[34] J. Felmlee,et al. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. , 2003, Kidney international.
[35] A. Go,et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. , 2003, Journal of the American Society of Nephrology : JASN.
[36] R. Gans,et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. , 2003, Kidney international.
[37] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[38] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[39] K. Nath,et al. Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] G. Hommel. A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .
[41] Wei Wu,et al. The organic anion transporter (OAT) family: a systems biology perspective. , 2015, Physiological reviews.
[42] Brenda R. Hemmelgarn,et al. Notice , 2012, Kidney International Supplements.
[43] Mai-Szu Wu,et al. p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[44] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[45] A. Levin,et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. , 2007, Kidney international.